Anterior ankle-foot orthosis effects on postural stability in hemiplegic patients

OBJECTIVES

To evaluate the effects of an anterior ankle-foot orthosis (AFO) on static and dynamic postural stability in hemiplegic patients.

DESIGN

A cross-sectional assessment of hemiplegic subjects with and without an AFO.

SETTING

Outpatient department of a rehabilitation hospital.

PATIENTS

A convenience sample of 24 subjects who had been prescribed an anterior AFO.

OUTCOME MEASURES

Postural sway index and postural symmetry (body weight distribution through the affected leg) when standing were measured as static postural stability. Maximal balance range in anterior-posterior and lateral directions and the affected leg's weight bearing after weight shift to affected side were measured as dynamic postural stability.

RESULTS

When wearing the anterior AFO, there was no significant difference and small effect size (r<0.3) in postural sway index (p = .35), postural symmetry (p = .21), and maximal balance range in anterior-posterior direction (p = .46). There was a significant improvement and large effect size (r>0.5) in lateral weight shifting (p<.01) and weight bearing through the affected leg after weight shifted to the affected side (p<.01).

CONCLUSIONS

The significant effects of the anterior AFO in long-term hemiplegic patients were on lateral weight shifting and weight bearing through affected leg after weight shifted to the affected side. Postural sway, postural symmetry, and anterior-posterior weight shifting were not significantly affected.

Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC)

INTRODUCTION

Epstein-Barr virus (EBV) is a ubiquitous human herpes virus with worldwide infection. It is associated with Burkitt's lymphoma in Africa and nasopharyngeal cancer (NPC) in Asian countries. EBV-coded DNA was found to be present in epithelial elements of NPC, and is usually associated with non-keratinizing (WHO type II) or undifferentiated carcinoma (WHO type III). Transcriptional analyses of EBV genome expression in NPC demonstrate an activated viral state in some of these tumors, leading to elevated levels of serum anti-viral capsid antigen (VCA) antibody in NPC patients.

METHODS

Eighty patients with histological diagnoses of NPC according to the 1978 WHO classification were referred to the Department of Radiation Oncology at Chang-Hua Christian Hospital for curative radiotherapy from 1985 to 1995. The patients were staged according to the AJCC staging system. A mean dose of 7,020 cGy in 39 fractions was delivered to the primary tumor using a telecobalt-60 unit or 6-10 MV X-ray linear accelerator. Pre- and postradiotherapy serum levels of anti-EBV/VCA IgG and IgA were determined for all patients using the indirect immunoperoxidase assay (IPA). Multivariate analysis was done to determine which factors affected the patients' treatment outcome and survival.

RESULTS

Five patients were excluded from this study due to incomplete radiotherapy, leaving 75 patients eligible for analysis. Overall local control was 77.3%, with a mean disease-free interval of 19.7 months. Factors affecting local control included radiation dose and pretreatment anti-EBV/VCA IgG titer. The overall 5-year actuarial survival for the 75 patients was 75%, with a median survival of 129.5 months. The 5-year actuarial survival rates for stage I + II, III, and IV patients were 90%, 40%, and 45%, respectively. Prognostic factors for survival included tumor histological type and pretreatment anti-EBV/VCA IgA titer, while prognostic factors for local control included total radiation dose received and pretreatment anti-EBV/VCA IgG titer.

CONCLUSION

We found that there was a significant difference in the geometric mean titer of anti-EBV/VCA IgA antibodies before and after radiotherapy. Prognostic factors affecting NPC patients' actuarial survival included tumor histology and pretreatment IgA titer, while prognostic factors for local control of NPC included total radiation dose received and pretreatment IgG titer.

Stapled colonic J-pouch-anal anastomosis without a diverting colostomy for rectal carcinoma

PURPOSE

Colonic J-pouch reconstruction is designed to improve functional outcome of coloanal anastomosis. Most surgeons use a diverting colostomy to avoid severe pelvic sepsis caused by anastomotic breakdown.

METHODS

We report the outcome of 30 consecutive patients with colonic J-pouch-anal anastomosis without a diverting colostomy performed between November 1992 and October 1993. All patients had carcinoma of the lower two-thirds of the rectum. Patients were seen every three months. Functional results were compared with those of 21 rectal cancer patients with straight coloanal anastomosis who underwent surgery in the same period and 20 normal patients.

RESULTS

There were two anastomotic leakages and one postoperative death. After one year, patients with pouch anastomosis had significantly less frequency of defecation and rectal urgency compared with those with straight anastomosis (P < 0.01); 48 percent of patients with straight anastomosis had more than five bowel movements per day, whereas all patients with pouch anastomosis had five or less bowel movements per day. Manometric studies showed maximum tolerable volume was significantly higher in patients with pouch anastomosis (81 vs. 152 ml; P < 0.01).

CONCLUSIONS

Stapled colonic J-pouch-anal anastomosis without a diverting colostomy is a reliable procedure that provides good, long-term functional results.

Monitoring lead pollution near a storage battery recycling plant in Taiwan, Republic of China

This study presents the distribution of blood lead levels and lead in various environmental samples (water, sediments, soils, and air) near the Shing-Yie storage battery recycling plant in Taiwan before (July 1990 to June 1991) and after (July 1992 to June 1993) amelioration. Before amelioration, the average blood lead levels in the neighborhood of the plant were in the range of 10.55 +/- 5.7 to 12.28 +/- 7.9 micrograms/dl. After amelioration, relatively lower average concentrations of blood lead (range 8.35 +/- 3.0 to 9.13 +/- 2.5 micrograms/dl) were generally found; however, these averages were still higher than that (7.79 +/- 3.5 micrograms/dl) from other lead-unpolluted areas of Taiwan. An exceedingly high geometric mean (GM) lead concentration (128 micrograms/L) was found in the downstream river water of the Tawulum River passing by the plant. The concentrations of lead (GM = 372 and 418 micrograms/g) in the downstream river sediments were higher than those (GM = 123 and 158 micrograms/g) in the upstream river sediments before and after amelioration, respectively. Furthermore, lead species in river sediments were analyzed by a sequential leaching technique. The sum of phases I, II, and III accounted for 83.7% of total lead at station R2 (nearest to the plant). Maximum lead concentration (GM = 2402 micrograms/g) in dust at the soil surface from station S1 (nearest to the plant) was much higher than those from the other stations by about 18 times before amelioration. However, the maximum value dropped to 1,155 micrograms/g after amelioration. On the whole, the geometric mean concentration of lead in dust at the soil surface nearest to the plant was > 1,000 micrograms/g and decreased to < 100 micrograms/g in the 15-30 cm depth soil about 2 km away from the plant. Before amelioration, the geometric mean lead concentration of 4.57 micrograms/m3 (range 0.102-37.6 micrograms/m3) in the air near the plant was higher than that at the background locations, the geometric mean value of which was 0.08 micrograms/m3.

The use of intranasal nitroglycerin to prevent pressor responses during intubation in general anesthesia--a comparison of various doses

BACKGROUND

Intranasal nitroglycerin (NTG) was first reported to successfully prevent an increase in arterial blood pressure following laryngoscopy and tracheal intubation by Hill et al. Various different effective dosages of NTG have been reported. Grover et al. indicated 0.75 mg of intranasal NTG to be the most suitable dose. However, no definite conclusion has yet been made. This study was designed to compare the efficacy of four different dosages of intranasal NTG (0.3, 0.5, 0.75, and 1.0 mg) in preventing pressor responses to laryngoscopy and tracheal intubation during the induction of general anesthesia.

METHODS

One hundred patients (ASA I or II) scheduled for elective surgery were included. These study subjects were divided into five groups and randomly assigned to four different dosages of intranasal NTG and a placebo. Each group consisted of 20 patients. The NTG solution was administered 1 min before the injection of thiopental. Systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP) and heart rate (HR) were recorded before the induction of anesthesia (T1), before laryngoscopy (T2), and at 0, 3, and 5 min after tracheal intubation (T3, T4, and T5 respectively).

RESULTS

In patients who received a placebo (control group), there were significant increases in SAP, MAP, HR and rate-pressure-product (RPP) associated with tracheal intubation. Tachycardia was noted in all experimental groups. The increases in MAP associated with tracheal intubation were significantly less in patients who received NTG of 0.5 mg or more but not 0.3 mg. Although 0.5 mg of NTG did attenuate the increases in SAP after tracheal intubation, the increases in SAP of the other three experimental groups were no less than that of the control group. Rate-pressure-product (RPP) values of the experimental groups were noted to be equal to or higher than those of the control group during the period of study. Contrary to the results of the study conducted by Grover et al., 0.75 mg of NTG did not attenuate the pressor responses.

CONCLUSIONS

Intranasal NTG does not attenuate the pressor responses to laryngoscopy and tracheal intubation.

Psoas abscess due to mucinous cystadenocarcinoma of the appendix: a case report

Psoas muscle abscess is an uncommon and challenging entity. The present report describes a 64-year-old man presenting with right flank mass. Abdominal computerized tomography showed a right psoas abscess. Extraperitoneal drainage was performed, and pathology revealed metastatic mucinous adenocarcinoma. After further study, laparotomy and right hemicolectomy were performed under the impression of colon cancer. The final pathology showed mucinous cystadenocarcinoma of appendix. The literature about the etiology, diagnosis and treatment of psoas abscess are reviewed. Additionally, the treatment and prognosis for mucinous cystadenocarcinoma of the appendix are noted.

Subclinical neurotoxicity of mercury vapor revealed by a multimodality evoked potential study of chloralkali workers

Pattern visual, brainstem auditory, and somatosensory evoked potential (EP) studies were performed on 26 chloralkali workers. The intensity of mercury vapor exposure in these workers was estimated from the individual working history. Mercury levels in blood, urine, and hair were determined with atomic absorption spectrometry. The EP findings were compared with those from individually matched normal subjects. In brainstem auditory and somatosensory EP studies, prolonged neural conduction times in the central nervous system (CNS) were found in workers exposed to mercury vapor. In the pattern visual EP study, mercury workers had higher interpeak amplitudes. Findings of this study suggested that chronic exposure to mercury vapor would affect the CNS functions. A multimodality EP study is a useful adjunct in evaluation of chronic mercury neurotoxicity, especially in an epidemiological study.

[Continuing hospice care of cancer--a three-year experience]

The hospice at Mackay Memorial Hospital was established in February 1990. A group of team workers including physicians, nurses, social workers and the clergy were involved in this holistic care program for terminal cancer patients. Four hundred and seventy-nine patients were eligible for the program up to February 1993. Regarding duration of stay, 62.5% of patients resided for 14 days. Those surviving under 90 days constituted 75.5% of patients. Fifty-one point eight percent of patients died in the hospice and 18.2% died at home soon after being discharged from the hospice. Pain is the most common symptom among the patients. Treatment strategies vary according to the three-step-ladder protocol designed by WHO. Total pain relief was achieved in 80% of patients. Opportune private talking and family conferences formed the basis of the "peer model". Through this model, treatment decisions including physical, psychosocial and spiritual issues were made. Before the peer model, only 36 (10.3%) patients agreed with the idea of hospice care, while 257 (73.6%) patients agreed after the model was established. Awareness of dying was evident in 412 (86%) patients. Two hundred and eighty (68%) patients became aware of the prospect of death through guessing, while the other 132 (32%) patients were informed by medical staff. Problems encountered by the team workers included 1) needs in education and training, 2) psychological pressure, 3) management of loss and grief, 4) needs in supportive system and 5) troubles caused by families' lying to patients. The team workers were satisfied with the quality of care in 38.4% of patients and fairly satisfied with 30.7% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone

Megestrol acetate and corticosteroid have been demonstrated to be effective in the treatment of anorexia in patients with advanced cancer. The purpose of this preliminary study is to evaluate the role of megestrol acetate and prednisolone in the treatment of anorexia induced during whole pelvis external irradiation. Fifty-two patients were randomized in this prospective study to either receive megestrol acetate (40 mg orally four times a day), prednisolone (10 mg orally three times a day), or placebo (1 tablet orally three times a day) for 21 consecutive days. Body weight, appetite, performance status, sense of well-being, and complications were assessed every 3 days. Both the megestrol acetate group and the prednisolone group showed improvement in body weight gain, appetite, performance status, and sense of well-being. Appetite improvement was statistically significant in the megestrol acetate group (P = 0.024) when compared with the placebo group. There were no complications during the 21-day trial.

Radiotherapy following simple hysterectomy in patients with invasive carcinoma of the uterine cervix

From January 1980 to December 1988, a total of 73 cases of invasive cervical cancer after simple hysterectomy were treated with radiotherapy. Seven patients were excluded due to incomplete treatment or loss of follow-up. Among the 66 patients, 52 had squamous cell carcinoma and 14 had adenocarcinoma or adenosquamous cell carcinoma. The patients were grouped as follows: group A, patients without gross residual tumor (n = 32); group B, patients with gross residual tumor (n = 23); and group C, patients with gross recurrent tumor (n = 11). All patients in groups A and B received radiotherapy immediately (within 4 months) following their simple hysterectomy. Patients in group C were treated six months to five years later. Different methods of radiotherapy were delivered during the two consecutive time periods. Before 1985, patients (n = 30) were irradiated with a dose of 45-50 Gy in the midpelvic plane, followed by a transvaginal boost of 30 Gy. After 1985, patients (n = 36) were treated with the same midpelvic dose, and boosted with 30 Gy by high-dose-rate brachytherapy. The overall five-year survival rate was 67%. The five-year survival rates were 81% in group A, 56% in group B, and 45% in group C. A low complication rate (10%) was obtained in our series.(ABSTRACT TRUNCATED AT 250 WORDS)

Radiotherapy for locally recurrent breast cancer

A total of 43 breast cancer patients were treated at the Department of Radiation Oncology, Mackay Memorial Hospital from January 1978 to December 1987 for postoperative local-regional recurrence. Twenty-six patients developed local recurrence within 12 months after surgery and 17 patients developed local recurrence after 12 months. The mean age for this group of patients was 52 years (range: 27-82). There were 26 postmenopausal and 17 premenopausal patients. Twenty-four patients had received chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) regimen. Four patients were excluded from this study due to incompletion of radiotherapy. Sites of local recurrence in the remaining 39 patients included: chest wall, single (8) and multiple (4); axilla (7); supraclavicular area (5); chest wall with regional node (11); and multiple regional nodes (4). All were free of distant metastasis at the initiation of radiotherapy. A mean tumor dose of 5000 cGy in 28 fractions was given over a 6-week period to the chest wall and draining lymphatics, using an AECL Theratron 80 or a CGR Alcyon MEV Cobalt-60 unit. The overall local control rate was 72%, and the 5-year local control rate was 59%. Nine patients experienced a second local recurrence, with a median interval of 8 months after radiotherapy. Four of them (4/9) also showed evidence of systemic disease at the same time. Distant metastasis, the major cause of mortality, appeared in 49% of the patients with a median interval of 22.8 months after radiotherapy. The three leading sites of distant metastasis were the bones (42%), lungs (37%) and liver (16%).(ABSTRACT TRUNCATED AT 250 WORDS)

Prevention of hypothermia during abdominal surgery: comparison of thermal tube and blanket

Twenty patients who received elective abdominal surgery for more than two hours were randomly assigned into two groups. Group 1 was warmed by using "EXACON" thermal therapy system model TT8200. Group 2 was warmed by using a thermal blanket of aquamatic K-thermia (electronic control), model PK-600 of American Hamilton medical systems. Other variables were kept constant, and the theater temperature was maintained at 24 degrees C. Core temperature was recorded every five minutes in a two hour period. There were statistically significant differences between these two groups intra-operatively. Decrease of temperature between these two groups had significant changes from 30 minutes to 2 hours (p less than 0.05). The warming effect of esophageal thermal tube was well controlled by directly warming the central compartment. However, the effect of blanket was unpredictable due to wet dressing and superficial warming of surgical fields. There were no side effects during the study.

The optimal dose of atropine via the endotracheal route

Fifty ASA class I or II patients, undergoing general or gynecological surgery under general anesthesia with endotracheal intubation, were randomly divided into five groups. Group I received 10 ug/kg atropine intravenously, group II to V received 10 ug/kg, 20 ug/kg, 30 ug/kg, 40 ug/kg, respectively via endotracheal route through an epidural catheter. All were given five manual deep breaths after the injection of atropine. The maximum increase in heart rate (MIHR) and the time to maximum heart rate (TMHR) were evaluated. There was no marked MIHR in group II. Group III had a MIHR similar to that of group I (17.5/min vs 20/min, p greater than 0.05), but had a longer TMHR than group I (120 sec vs 82.5 sec, p less than 0.005). Groups IV and V had greater MIHR than group I (28.7 and 29.5 vs 20/min, p less than 0.005), and a TMHR similar to that of group I (85 and 90.2 vs 82.5 sec, p greater than 0.05). For emergency procedures, if atropine must be given without an intravenous catheter, 30 ug/kg or more given endotracheally can achieve an effect comparable to that of 10 ug/kg given intravenously.